Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Arena Pharmaceuticals News Editors

News Widget

Display the Arena Pharmaceuticals news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Arena Pharmaceuticals News

News on Arena Pharmaceuticals (Ticker: ARNA) continually updated from thousands of sources around the net.

Tuesday | Seeking Alpha

FDA Obesity Drug Decisions On June 17 And July 27 Will Affect These Stocks

The FDA has two multi-billion dollar decisions to make this summer regarding obesity and weight loss treatments.

Comment?

Related Topix: Financial Markets, Startups, VIVUS, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Food and Drug Administration

Tuesday May 29 | The Motley Fool

2012's 2 Best Health-Care Stocks

The following video is part of our "Motley Fool Conversations" series, in which health-care editor/analyst David Williamson discusses topics around the investing world.

Comment?

Related Topix: Startups, Threshold Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Tue May 22, 2012

Wall St. Cheat Sheet

Healthcare Biz Recap: Pfizer REJECTION, Alexion in the Big Leagues

Shares of Bayer slip, but Onyx Pharmaceuticals moves up following word that a Phase 3 trial of Nexavar tablets in patients with certain lung cancers failed to meet its primary endpoint of improving overall survival.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Startups, Onyx Pharmaceuticals

Mon May 21, 2012

Benzinga

The Strongest Small-Caps in the Market

Traders who are comfortable with a high level of risk/reward frequently will gravitate to the small-cap space where big gains in a short amount of time are commonplace.

Comment?

Related Topix: Biotech, Financial Markets, Medicine, Healthcare Industry

Benzinga

Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment...

Arena Pharmaceuticals, Inc. today announced the completion of an underwritten public offering of 12,650,000 shares of its common stock, including 1,650,000 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Wed May 16, 2012

SanLuisObispo.com

Study: US clears drugs faster than Europe, Canada

Researchers say the U.S. approved more new medicines in less time than Europe and Canada in the last decade, challenging long-standing criticisms that the Food and Drug Administration lags behind its peers in clearing important new drugs.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Minyanville

Arena Pharmaceuticals and PowerShares QQQ Trust Among Most Active...

SINA released its first-quarter results yesterday, and investors have responded favorably despite the Chinese Internet company's first-quarter loss, which was $13.3 million or $0.21 per share.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Bloomberg

U.S. Stock Futures Fluctuate; J.C. Penney Sinks

U.S. stock-index futures fluctuated between gains and losses as speculation reports today may show increases in housing starts and industrial production offset concern Greece will be forced to exit the euro.

Comment?

Related Topix: Retail, JC Penney, Europe, Greece, World News, Biotech, Medicine, Healthcare Industry, Construction, Berkshire Hathaway, Investment Services, Financial Markets, Karolos Papoulias

Tue May 15, 2012

Bloomberg

Arena, J.C. Penney, Medallion, TriQuint: U.S. Equity Preview

Shares of the following companies may have unusual moves in U.S. trading tomorrow.

Comment?

Related Topix: Semiconductors, Electronics, TriQuint Semiconductor, JC Penney, Retail, Biotech, Medicine, Healthcare Industry, Medallion Financial, Financial Services, US News

Wall St. Cheat Sheet

What's Moving These Hot Stocks: Arena Pharmaceuticals and Renren

Arena Pharmaceuticals, Inc. shares climbed high, as the market pretty much believing that FDA approval of the company's experimental obesity drug Lorcaserin is guaranteed.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Social Software, Startups, Facebook

Mon May 14, 2012

Pharmaceutical Online

Eisai Inc. Expands Marketing And Supply Agreement With Arena For Anti-Obesity Agent Lorcaserin

Eisai Co., Ltd. announced recently that its U.S. subsidiary Eisai Inc. has expanded the marketing and supply agreement it concluded with Arena Pharmaceuticals GmbH, the Swiss subsidiary of U.S.-based Arena Pharmaceuticals Inc.

Comment?

Related Topix: Biotech, Medicine, Eisai, Healthcare Industry, Eisai Co, Marketing, Food and Drug Administration

Forbes.com

With Biotechs Back In Limelight, OPKO's Alzheimer's...

As Pfizer 's rheumatoid arthritis pill and Arena Pharmaceuticals' weight-loss drug got positive nods from federal advisory panels, the role of biotech companies in finding new treatments for major medical disorders is getting renewed investor attention.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Food and Drug Administration, Financial Services

Sat May 12, 2012

Barron's

Arena Winners: Deerfield, Fidelity, QVT

Here's a "wow" stock for you: Arena Pharmaceuticals' 72% surge on an FDA panel's obesity-drug backing brings the shares' year-to-date gain to 234%. This is a small-cap stock beloved by a handful of hedge funds; it's not one you see in big mutual-fund or ETF doses.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Blog News

SFGate

FDA panel backs Arena weight-loss pill lorcaserin

PHARMACEUTICALS FDA panel endorses weight-loss drug Arena Pharmaceuticals jumped the most ever Friday after the company's weight-loss pill gained the backing of an advisory panel, putting two obesity drugs in line for U.S. approval almost two years after regulators rejected them as too risky.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, San Diego, CA, La-Jolla, CA, Orexigen Therapeutics

Fri May 11, 2012

MarketWatch

Stocks to Watch: Stocks to watch Friday: Arena, Nordstrom, Nvidia

Among the stocks that could see active trade in Friday's session are Arena Pharmaceuticals Inc., Nordstrom Inc.

Comment?

Related Topix: Nordstrom, Retail, Apparel, Financial Markets, Biotech, Medicine, Healthcare Industry, Dillards, Food and Drug Administration

The Japan News .Net

Arena soars after weight-loss pill recommended for approval

Arena Pharmaceuticals Inc. jumped the most ever after the company's weight-loss pill gained the backing of an advisory panel, putting two obesity drugs in line for U.S. approval almost two years after regulators rejected them as too risky.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

MediLexicon

Obesity Drug Lorcaserin Gets Positive Vote From FDA Panel

Lorcaserin, an investigational obesity drug, was given a positive recommendation by the Endocrinologic and Metabolic Drugs Advisory Committee, which advises the Food and Drug Administration .

Comment?

Related Topix: Food and Drug Administration, Supplement, Hypothalamus, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Health

BioSpace

Arena Pharmaceuticals, Inc. Wins Positive FDA Panel Vote for Obesity...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Arena Pharmaceuticals, Inc.

Comment?

Related Topix: Arena Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Eisai, Food and Drug Administration, Eisai Co, Marketing

AmericanBankingNews.com

Arena Pharmaceuticals Upgraded by Jefferies Group to "Buy"

The firm currently has a $1.00 price target on the stock, down from their previous price target of $9.00. Several other analysts have also recently commented on the stock.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Investment Banking, Financial Services, Jefferies Group, Investment Services

Sys-Con Media

MobileStockPicks.com Breakout Watch List Arena Pharmaceuticals Inc....

Their main focus is on U.S. equities with the potential to deliver gains of 50%-100% or more.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cell Phones, Cellphones, Electronics

Los Angeles Jobs

Also on Topix